SAO PAULO (Reuters) – The National Health Surveillance Agency (Anvisa) on Saturday determined the precautionary ban on batches of Chinese vaccine against Covid-19 CoronaVac, prohibiting the distribution and use of batches in a plant not approved in the emergency use authorization , said the regulator in a statement.
According to the statement, Anvisa was informed the day before by the Butantan Institute that Sinovac, the manufacturer of CoronaVac, sent to Brazil 25 batches in the vial-ampoule presentation (single dose and two doses), totaling 12,113,934 doses.
Read Also
- At least a million connected objects infected by a security breach, says Microsoft Nov 24, 2022
- BMW M4, what a disappointment at the moose test | FormulaPassion.it Aug 26, 2021
- They seize more than a ton of illegally extracted hake in La Araucanía: one detainee Dec 18, 2022
- Hamilton: “I thought I had an advantage over Verstappen” | FormulaPassion.it Sep 20, 2021
- IMSS approves project to guarantee workers rights Aug 31, 2021
- How is Google Workspace, the new productivity tool that replaces G Suite Oct 6, 2020
- New Lamborghini Countach: the wait is over. Find out soon on Gazzetta.it Aug 13, 2021